Page 3 - Drug Processing Technology News Today

Gannex Pharma has dosed the first subject in Phase II trial of ASC42 for the treatment of primary biliary cholangitis (PBC) patients.

NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial of PrimeC.

Akston Biosciences is set to commence a Phase II trial of its protein subunit Covid-19 vaccine, AKS-452, as a booster in the Netherlands.

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A sma...

Ukraine’s conflict has knock-on effects on the Covid-19 pandemic as supplies of Sputnik V vaccine to Asian, African, and South American countries now in question.

The Russian invasion will not only affect Ukraine’s trade flows but also global flows as sanctions are placed on Russia.

CureVac has dosed the first subject in a Phase I trial of its seasonal influenza second-generation mRNA vaccine candidate, CVSQIV.

Middle East & Africa witnessed a 17.1% drops in IT hiring activity in the pharma industry in December 2021, according to GlobalData’s Job Analytics index

Oncorena has started a Phase I/II trial of its drug candidate orellanine to treat individuals with advanced kidney cancer on dialysis.

The US FDA cleared IND application of Viridian Therapeutics to commence Phase I trial of its antibody VRDN-002 to treat thyroid eye disease.